for the LIVE-AIR Study Group, n/a

Humanigen, Inc
Burlingame,, California, United States

Humanigen, Inc (Grant/Research Support)

Presentation(s):

• 40 - Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial

  On Demand